Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Mohan Goud, V.
- Development and Validation for Estimation of Abiraterone acetate in Bulk and Pharmaceutical Dosage Form by UPLC
Abstract Views :161 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutical Analysis, Joginpally B.R Pharmacy College, Yenkapally, Moinabad, R.R. Dist. Telangana, IN
1 Department of Pharmaceutical Analysis, Joginpally B.R Pharmacy College, Yenkapally, Moinabad, R.R. Dist. Telangana, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 6 (2019), Pagination: 3029-3032Abstract
A simple, Robust, stability indicated method was developed for the estimation of Abiraterone by RP-UPLC technique. Chromatographic conditions used are, stationary phase SB C8 100 x 3.0 mm, 1.8. Mobile phase 0.01N NaH2PO4: Acetonitrile in the ratio of 60:40v/v and flow rate were maintained at 0.3 ml/min, detection wave length was 235 nm, and column temperature was set to 30oC. System suitability parameters were studied by injecting the standard six times and results were well under the acceptance criteria. Linearity study was carried out between 25% to150 % levels, R2 value was found to be as 0.999. Precision was found to be 0.6 for repeatability and 1.1 for intermediate precision. LOD and LOQ are 0.09μg/ml and 0.27μg/ml respectively. Degradation studies of Abiraterone were done, in all conditions and it is within the acceptable range.Keywords
UPLC, Abiraterone Acetate, Mobile Phase, Method Development.
References
- Food and Drug Administration Approves Abiraterone for Treatment of Men with Advanced Prostate Cancer.
- Salem M, Garcia JA. Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer. Curr Oncol Rep 2011(13):92-96.
- National Institute for Health and Care Excellence (NICE). Guide to the processes of technology appraisal. London: NICE; 2014.https://www.nice.org.uk/article/pmg19/chapter/foreword. Accessed 21 Mar 2016.
- Martins V, Asad Y, Wilsher N, Raynaud F, A validated liquid chromatographic– tandem mass spectroscopy method for the quantification of abiraterone acetate and abiraterone in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2006; 843(2):262-267.
- Gaurav S, Punde R, Farooqui J, Zainuddin M, Rajagopal S, Mullangi R, Development and validation of a highly sensitive method for the determination of abiraterone in rat and human plasma by LC-MS/MS-ESI: application to a pharmacokinetic study. Biomed Chromatogr. 2012;26(2):761-8.
- Kumar SV, Rudresha G, Gaurav S, Zainuddin, Dewang P, Kethiri RR, Rajagopal S, Mullangi R, Validated RPHPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats. Biomed Chromatogr. 2013; 27(2): 203-7.
- Khdera A, Darwish I, Bamanea F, Analysis of abiraterone stress degradation behavior using liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry. J Pharm Biomed Anal. 2013; 23:74-77.
- Gong A, Zhu X, β-cyclodextrin Sensitized Spectrofluorimetry for the Determination of Abiraterone Acetate and Abiraterone. J. Fluoresc. 2013; 23(6):1279-86. 2014. https://www.nice.org.uk/article/pmg19/chapter/foreword. Acces- sed 21 Mar 2016